Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Heel Inc. Launches Reboost™ Cold and Flu Products Providing Cost-Effective, Multi-Symptom Relief with Ingredients Found in Nature
  • USA - English


News provided by

Chandler Chicco Agency

Oct 15, 2013, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Reboost™ Cold, Cough and Flu Products
Reboost™ Cold, Cough and Flu Products

Albuquerque, NM (PRWEB) October 15, 2013 -- Heel Inc. – a pharmaceutical company, which makes medicines from ingredients found in nature – today announced the launch of the Reboost™ product line, which includes four of the company’s trusted homeopathic cold, cough and flu products. The product line is now available at a variety of fine natural health stores and pharmacies, including Whole Foods Market and Sprouts Farmers Market. More information on the new product line and a store locator can be found at ReboostColdFlu.com.

With a growing patient base interested in natural therapies, I’m pleased to provide products like Reboost™, which offer multi-symptom relief without the side effects that may accompany over-the-counter treatments.

Post this

Americans of all ages and backgrounds are affected by the cold and flu each year, leading to great inconvenience from missed days of work and school. In fact, the U.S. Centers for Disease Control and Prevention (CDC) estimates the common cold is responsible for 22 million missed school days annually. While there is no cure for the common cold, symptomatic treatment is key. With elevated consumer interest in natural yet effective products, the Reboost™ brand is just what the doctor ordered – get relief without common side effects such as drowsiness and rebound effect.

The Reboost™ line of products includes Nasal Spray (0.68 fluid ounces) for the temporary relief of minor nasal symptoms, Throat Spray (0.68 fluid ounces) for the temporary relief of minor pain from sore throat and pain from canker sores, Tablets (100 ct) for the temporary relief of minor flu symptoms and Cough Syrup (4.23 fluid ounces) for minor cough and chest congestion relief. Reboost™ products can be used by adults and children four years and above.

“There is growing consumer demand for natural alternatives to traditional over-the-counter cold and flu medications,” said Cliff Clive, CEO of Heel Inc. “We are excited to offer an affordable product line to the marketplace that provides multi-symptom relief for the cold and flu. Reboost™ products not only alleviate symptoms effectively, but do so without causing harmful side effects. As a trusted name in homeopathic medicines for decades, Heel is committed to products that strengthen the body’s natural defenses.”

“As a physician, I recommend a range of interventions from traditional medicines to natural, homeopathic options,” said Dr. Sezelle Gereau Haddon, an Ear, Nose & Throat Physician from the Center for Health and Healing. “With a growing patient base interested in natural therapies, I’m pleased to provide products like Reboost™, which offer multi-symptom relief without the side effects that may accompany over-the-counter treatments.”

Most recently, Reboost™ was recognized at the 2013 Natural Products Expo West (NPEW) with a NEXTY nomination from New Hope – a leading resource for the natural, organic and healthy-lifestyle products industry. NEXTY nominations are given by New Hope to upcoming products that they believe will create buzz in the natural products landscape.

Reboost™ Cold, Cough and Flu Products
Reboost™ Cough Syrup, which contains four natural ingredients out of six actives, relieves minor cough and chest congestion and does not include artificial flavors or ingredients known to cause drowsiness. Reboost™ Nasal Spray, which contains five natural ingredients out of eight actives, relieves minor nasal congestion, sinus headache and pressure, and cold/flu nasal symptoms. This decongestion medicine does not contain ingredients known to cause drowsiness or rebound effect. Reboost™ Throat Spray, which contains all natural ingredients, relieves minor pain from sore throat and pain from canker sores, and does not contain ingredients known to cause drowsiness. Reboost™ Tablets, which contain four natural ingredients out of five actives, relieve minor body aches, headache and fatigue.

About Heel Inc.
Heel is a homeopathic pharmaceutical company that develops, manufactures and distributes medicines. Heel medicines are available through healthcare providers and fine natural product stores throughout the United States. For more information on other Heel products and their use, please visit http://www.heelusa.com.

These statements have not been reviewed by the Food and Drug Administration. They are supported by traditional homeopathic principles. For more information on Reboost™ visit ReboostColdFlu.com.

Amy Larkin, Chandler Chicco Agency, +1 (202) 609-6019, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.